Jonathan Corren1), Pascal Chanez2), Mario Castro3), Leonardo Fabbri4), Vijay N.Joish5), Robert E.Evans6), Neil M.H.Graham7), Sara Villeneuve8), Gaelle Bego-Le Bagousse9), Christine Taniou10), Puneet Mahajan11), Ariel Teper12), Gianluca Pirozzi12), Laurent Eckert9)
1)David Geffen School of Medicine at UCLA, Medicine, Allergy & Immunology, 2)Aix-Marseille Universite, U1067 INSERM Respiratory, 3)Washington University School of Medicine, Department of Medicine, 4)University of Modena and Reggio Emilia, Department of Medicine, NOCSAE, 5)Regeneron Pharmaceuticals, Inc., Health Economics and Outcomes Research, 6)Regeneron Pharmaceuticals, Inc., Clinical Sciences, 7)Regeneron Pharmaceuticals, Inc. , Program Direction, 8)Ividata Stats, 9)Sanofi R&D, Global Health Economics and Outcomes Research, 10)Experis-IT, BU Pharma and Industry, 11)Sanofi R&D, Global Health Economics and Outcomes Research, 12)Sanofi R&D, Research and Development
Annals of The Japanese Respiratory Society 6(suppl): 338-338, 2017.